SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-006231
Filing Date
2023-05-11
Accepted
2023-05-11 16:45:44
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa_10q.htm   iXBRL 10-Q 733171
2 CERTIFICATION edsa_ex311.htm EX-31.1 11695
3 CERTIFICATION edsa_ex312.htm EX-31.2 9841
4 CERTIFICATION edsa_ex321.htm EX-32.1 3663
5 CERTIFICATION edsa_ex322.htm EX-32.2 4034
  Complete submission text file 0001654954-23-006231.txt   3612896

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA edsa-20230331.xsd EX-101.SCH 42111
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20230331_lab.xml EX-101.LAB 225405
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20230331_cal.xml EX-101.CAL 36109
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20230331_pre.xml EX-101.PRE 188566
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20230331_def.xml EX-101.DEF 86910
53 EXTRACTED XBRL INSTANCE DOCUMENT edsa_10q_htm.xml XML 563660
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 23911811
SIC: 2834 Pharmaceutical Preparations